Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$10.67
+1.1%
$11.29
$10.03
$18.80
$5.28B1.444.56 million shs1.04 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$421.11
+0.8%
$437.26
$398.50
$548.88
$34.12B1.39554,962 shs446,903 shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$819.27
-0.9%
$841.16
$711.40
$972.53
$776.79B0.343.66 million shs889,998 shs
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
$52.98
-1.0%
$53.97
$46.30
$61.12
$76.17M1.135,315 shs8,836 shs
PetIQ, Inc. stock logo
PETQ
PetIQ
$30.98
$30.90
$15.09
$31.06
$925.99M1.73480,624 shsN/A
Pfizer Inc. stock logo
PFE
Pfizer
$25.13
-0.3%
$26.12
$24.48
$31.54
$142.50B0.6136.68 million shs18.75 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$163.66
+0.5%
$166.55
$144.80
$200.33
$73.29B0.943.02 million shs435,535 shs
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
+0.24%-2.86%-5.39%-12.57%-33.72%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
+0.01%-1.05%-9.91%+0.14%-21.28%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-2.99%-1.25%-6.24%+4.12%+6.66%
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
+0.17%-0.93%-2.83%-5.58%+6.03%
PetIQ, Inc. stock logo
PETQ
PetIQ
0.00%0.00%0.00%0.00%+74.14%
Pfizer Inc. stock logo
PFE
Pfizer
-1.44%-3.76%-5.54%-5.15%-8.69%
Zoetis Inc. stock logo
ZTS
Zoetis
+0.79%-0.73%-1.78%-1.79%-1.90%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
4.2181 of 5 stars
4.23.00.00.32.93.30.6
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
4.2854 of 5 stars
3.42.00.03.73.12.51.3
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.8327 of 5 stars
2.45.03.34.03.42.51.9
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/AN/AN/AN/AN/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
0.4823 of 5 stars
1.20.00.00.00.61.71.3
Pfizer Inc. stock logo
PFE
Pfizer
4.9887 of 5 stars
3.33.04.24.23.33.33.1
Zoetis Inc. stock logo
ZTS
Zoetis
4.6317 of 5 stars
3.53.04.20.43.72.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.43
Hold$15.1742.21% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.80
Moderate Buy$533.7526.75% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.85
Moderate Buy$1,009.7223.25% Upside
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
2.79
Moderate Buy$52.98N/A
PetIQ, Inc. stock logo
PETQ
PetIQ
2.33
Hold$30.50-1.55% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.63
Moderate Buy$31.9227.06% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
3.08
Buy$215.9031.92% Upside

Current Analyst Ratings Breakdown

Latest ZTS, ELAN, PAWZ, PFE, LLY, PETQ, and IDXX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/6/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$1,146.00
3/6/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $12.00
3/5/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$970.00 ➝ $1,100.00
2/27/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$200.00 ➝ $205.00
2/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $17.00
2/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $13.00
2/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$20.00 ➝ $19.00
2/21/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $16.00
(Data available from 3/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.44B1.19$2.20 per share4.84$12.63 per share0.84
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.90B8.76$10.55 per share39.92$19.48 per share21.62
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$45.04B17.25$13.36 per share61.34$15.05 per share54.44
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/AN/AN/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
$1.10B0.84$2.68 per share11.54$7.58 per share4.09
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.24$3.94 per share6.38$15.81 per share1.59
Zoetis Inc. stock logo
ZTS
Zoetis
$9.26B7.92$7.35 per share22.26$10.65 per share15.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$1.23B$0.6726.6611.982.504.60%6.78%3.03%5/6/2025 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$887.87M$10.6739.4631.013.4122.78%55.82%26.48%5/7/2025 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$10.59B$11.7169.9626.331.4023.51%85.24%16.19%5/1/2025 (Estimated)
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/A24.38N/AN/AN/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
$2.13M$0.3979.4424.59N/A1.20%18.75%5.15%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4117.828.290.6412.62%19.47%8.09%4/29/2025 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.49B$5.4729.9224.252.7826.86%53.82%18.86%5/1/2025 (Estimated)

Latest ZTS, ELAN, PAWZ, PFE, LLY, PETQ, and IDXX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/25/2025Q4 2024
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.15$0.14-$0.01-$0.02$1.01 billion$1.02 billion
2/13/2025Q4 2024
Zoetis Inc. stock logo
ZTS
Zoetis
$1.37$1.40+$0.03$1.29$2.30 billion$2.32 billion
2/6/2025Q4 2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.45$5.32-$0.13$4.88$13.42 billionN/A
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.000.73%+15.21%51.24%11 Years
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
$0.350.66%N/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.85%+2.50%121.99%16 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.001.22%+18.66%36.56%14 Years

Latest ZTS, ELAN, PAWZ, PFE, LLY, PETQ, and IDXX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2025
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.501.2%4/21/20254/21/20256/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.66
2.55
1.31
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.28
1.31
0.95
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.00
1.15
0.97
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
1.68
2.58
1.68
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Zoetis Inc. stock logo
ZTS
Zoetis
1.09
1.75
1.08

Institutional Ownership

CompanyInstitutional Ownership
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/A
PetIQ, Inc. stock logo
PETQ
PetIQ
94.99%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,800494.61 million491.54 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10,80081.06 million80.16 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
39,000948.17 million948.08 millionOptionable
ProShares Pet Care ETF stock logo
PAWZ
ProShares Pet Care ETF
N/A1.08 millionN/ANot Optionable
PetIQ, Inc. stock logo
PETQ
PetIQ
1,93329.89 million27.01 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.67 billion5.66 billionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
14,100447.79 million447.08 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$10.66 +0.12 (+1.09%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$421.11 +3.40 (+0.81%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$819.26 -7.50 (-0.91%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

ProShares Pet Care ETF stock logo

ProShares Pet Care ETF BATS:PAWZ

$52.98 -0.56 (-1.05%)
As of 12:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The ProShares Pet Care ETF (PAWZ) is an exchange-traded fund that is based on the FactSet Pet Care index. The fund tracks a tier-weighted index of global equities related to pet ownership. PAWZ was launched on Nov 5, 2018 and is managed by ProShares.

PetIQ stock logo

PetIQ NASDAQ:PETQ

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

Pfizer stock logo

Pfizer NYSE:PFE

$25.12 -0.09 (-0.34%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Zoetis stock logo

Zoetis NYSE:ZTS

$163.66 +0.84 (+0.52%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.